Improvement of measurements of old duration ITON patients in our study was quite promising in comparison to the study of Acar et al. who treated 16 late stage optic neuropathy patients of mixed etiology with intravitreal EPO and concluded inefficacy of EPO treatment in improving BCVA or VER values [53]. This evidence concerns the gene EPO and Optic neuropathy.